Masakazu Sugaya
Chubu Rosai Hospital(JP)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Glycosylation and Glycoproteins Research, Immune Cell Function and Interaction
Most-Cited Works
- → Identification of a New Cancer/Germline Gene,KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma(2006)112 cited
- → Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations(2008)92 cited
- → Haplotype Loss of HLA Class I Antigen as an Escape Mechanism from Immune Attack in Lung Cancer(2005)89 cited
- → Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer(2011)82 cited
- → Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro(2007)79 cited
- → Establishment of 15 Cancer Cell Lines From Patients With Lung Cancer and the Potential Tools for Immunotherapy(2002)67 cited
- → Survival and prognostic factors of surgically resected T4 non-small cell lung cancer(2003)64 cited
- → A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma(2005)61 cited
- → Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese(2005)60 cited
- → Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer(2020)59 cited